门静脉性肺动脉高压1例报告

殷鑫; 高卉; 张雨; 张明媛; 金清龙; 温晓玉

doi:10.3969/j.issn.1001-5256.2018.10.030

门静脉性肺动脉高压1例报告

DOI: 10.3969/j.issn.1001-5256.2018.10.030

吉林大学第一医院肝胆胰内科

基金项目:

国际科技合作项目(20150414016GH)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1953
- HTML全文浏览量: 3
- PDF下载量: 329
- 被引次数: 0
出版历程
- 出版日期: 2018-10-20

A case of portopulmonary hypertension

Department of Hepatology, The First Hospital of Jilin University

Research funding:

摘要

摘要:
<正>1病例资料患者女性,47岁,因"乙型肝炎病原学阳性12年,间断呕血、黑便3年余,乏力、腹胀10 d,恶心、呕吐2 d"于2017年7月24日入本院。患者12年前因乏力、腹胀住院治疗,明确诊断为肝炎后肝硬化-乙型-失代偿期、脾大,同年行脾切除术,3年前因间断呕血、黑便住院治疗,并先后2次行食管-胃静脉曲张套扎术,后复查胃镜未见曲张静脉,就诊期间多次监测
- 门脉性肺动脉高压 /
- 肝硬化 /
- 病例报告
- portopulmonary hypertension /
- liver cirrhosis /
- case reports

HTML全文

参考文献(14)

[1]MANCUSO L, SCORDATO F, PIERI M, et al.Management of portopulmonary hypertension:New perspectives[J].World J Gastroenterol, 2013, 19 (45) :8252-8257.

[2] ALDENKORTT F, ALDENKORTT M, CAVIEZEL L, et al.Portopulmonary hypertension and hepatopulmonary syndrome[J].World J Gastroenterol, 2014, 363 (25) :8072-8081.

[3]KROWKA MJ, SWANSON KL, FRANTZ RP, et al.Portopulmonary hypertension:Results from a 10-year screening algorithm[J].Hepatology, 2006, 44 (6) :1502.

[4]MICHELAKIS ED, WILKINS MR, RABINOVITCH M.Emerging concepts and translational priorities in pulmonary arterial hypertension[J].Circulation, 2008, 118 (14) :1486-1495.

[5]ALDENKORTT F, ALDENKORTT M, CAVIEZEL L, et al.Portopulmonary hypertension and hepatopulmonary syndrome[J].World J Gastroenterol, 2014, 363 (25) :8072-8081.

[6]DUBROCK HM, RODRIGUEZ-LOPEZ JM, LEVARGE BL, et al.Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension[J].Pulm Circ, 2016, 6 (4) :498.

[7]COLLE IO, MOREAU R, GODINHO E, et al.Diagnosis of portopulmonary hypertension in candidates for liver transplantation:A prospective study[J].Hepatology, 2003, 37 (2) :401-409.

[8]SHI LN, YU CC, CHENG J, et al.Transcranial Doppler ultrasound foaming test (C-TCD) in the screening of cryptogenic stroke complicated with patent foramen ovale (PFO) [J].J Apoplexy Nerv Dis, 2017, 34 (1) :48-50. (in Chinese) 史丽娜, 于成超, 成江, 等.经颅多普勒发泡实验在筛查隐源性卒中合并卵圆孔未闭的应用价值[J].中风与神经疾病杂志, 2017, 34 (1) :48-50.

[9]LIBERAL R, GRANT CR, BAPTISTA R, et al.Porto-pulmonary hypertension:A comprehensive review[J].Clin Res Hepatol Gastroenterol, 2015, 39 (2) :157-167.

[10]LIU YJ, LI T.An excerpt of International Liver Transplant Society practice guidelines:Diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension (2016) [J].J Clin Hepatol, 2016, 32 (10) :1838-1842. (in Chinese) 刘以俊, 李涛.《2016年国际肝移植学会实践指南:肝肺综合征与门脉性肺动脉高压的诊断与管理》摘译[J].临床肝胆病杂志, 2016, 32 (10) :1838-1842.

[11]OGIHARA Y, YAMADA N, DOHI K, et al.Effects of low-dose tolvaptan on electrolyte abnormality and hemodynamic parameters in a liver cirrhosis-associated portopulmonary hypertension patient:Acase report[J].Exp Ther Med, 2017, 13 (1) :269-272.

[12]MARON BA, OPOTOWSKY AR, LANDZBERG MJ, et al.Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure:A pilot study[J].Eur J Heart Fail, 2013, 15 (3) :277-283.

[13]PRESTON IR, SAGLIANI KD, WARBURTON RR, et al.Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension[J].Am J Physiol Lung Cell Mol Physiol, 2013, 304 (10) :L678-L688.

[14]SAVALE L, SATTLER C, COILLY A, et al.Long term outcome in liver transplantation candidates with portopulmonary hypertension[J].Hepatology, 2017, 64 (2) :1683-1692.

施引文献

资源附件(0)

访问统计